The US Food and Drug Administration’s top food official offered a grim take on the agency’s appropriation for the rest of fiscal year 2024, a view dietary supplement industry stakeholder may share about a proposed FDA reorganization he says will work despite their concerns.
“We've definitely heard, we've heard the concern loud and clear, although we do continue to remain committed to the proposed structure that we have here,” said Jim Jones, FDA deputy...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?